Research Topics
Species | Jose G GuillemSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancerJose G Guillem
Department of Surgery Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 241:829-36; discussion 836-8. 2005....
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasmsJinru Shia
Department of Pathology, Memorial Sloan Kettering, Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 29:96-104. 2005....
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapyTobias Leibold
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 1077, New York, NY 10021, USA
J Clin Oncol 26:2106-11. 2008..The aim of this study was to examine the prognostic significance of location of involved lymph nodes in rectal cancer patients after preoperative chemoradiotherapy...
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery aloneAviram Nissan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:4078-84. 2006..CONCLUSION Patients with T2-3, N0 rectal cancers and either lymphovascular invasion or elevated CEA levels have reduced survival and a higher incidence of PR, and should be considered for future randomized trials...
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysisTobias Leibold
Department of Surgery Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 18:2783-9. 2011..We prospectively evaluated tumor response with (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) early in the course of preoperative CRT...
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, NY 10021, USA
Ann Surg Oncol 11:955-61. 2004..Expression of p27 in the residual rectal cancer may therefore identify patients with disease likely to be refractory to standard therapy and for whom investigational approaches should be strongly considered...
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancerJose G Guillem
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Am Coll Surg 199:1-7. 2004..08, 0.02 and p = 0.03, 0.01, respectively). CONCLUSIONS: Our results indicate that FDG-PET assessment of locally-advanced rectal cancer response to preoperative chemoradiation may predict longterm outcomes...
Squamous-cell carcinoma of the anal canal: predictors of treatment outcomeRamin Roohipour
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 51:147-53. 2008..The incidence of anal canal squamous-cell carcinoma is increasing. Limited data exist on predictors of treatment failure. This study was designed to identify predictors for relapse/persistence after first-line therapy...
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end pointJose G Guillem
Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 1077, New York, NY 10021, USA
J Clin Oncol 23:3475-9. 2005..However, because the accuracy of this approach has not been established, we conducted a prospective analysis to determine the operating surgeon's ability to assess response using DRE...
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluationJeannine A Ruby
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Dis Colon Rectum 55:378-86. 2012..At present there is no defined role for routine FDG-PET in the preoperative evaluation of nonmetastatic rectal cancer...
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:4642-60. 2006....
Effects of obesity in rectal cancer surgeryHueylan Chern
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Am Coll Surg 211:55-60. 2010..In this study, we evaluate whether higher body mass index (BMI) compromises surgical resection in patients with locally advanced, mid-to-low rectal cancer after neoadjuvant therapy, adversely affecting long-term oncologic outcomes...
Squamous-cell carcinoma of the rectum: a rare but curable tumorCaio S R Nahas
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Dis Colon Rectum 50:1393-400. 2007..This study was designed to evaluate one institution's experience with treatment outcomes for rectal squamous-cell carcinoma...
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservationJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 245:88-93. 2007....
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonographyFrancesco Stipa
Department of Surgery-Colorectal Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, New York 10021, USA
Ann Surg Oncol 13:1047-53. 2006..Because pCR seems to be associated with better outcome, an understanding of the factors governing the response to CMT should be pursued...
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort studyDavid B Chessin
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 12:104-10. 2005..Because other complications are not increased, RAM flap closure of the perineal wound should be strongly considered in this patient population...
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcomeJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Am J Surg Pathol 28:215-23. 2004..Our results demonstrate distinct morphologic features in treated rectal carcinomas that are prognostically relevant...
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty serviceDavid B Chessin
Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 200:876-82; discussion 882-4. 2005....
Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonrespondersRamesh Rengan
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Clin Colorectal Cancer 5:413-21. 2006..However, patients with cT3 disease that is not downstaged by RT have an increased risk of local failure. These data underscore the impact of tumor response to radiation on long-term oncologic outcome...
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessmentBridget N Fahy
Department of Surgery, Division of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:1735-43. 2007..Predicting rectal carcinoid behavior based exclusively on tumor size is imprecise. We sought to identify factors associated with outcome and incorporate them into a pre-operative risk stratification scheme...
A predictive model for lymph node yield in colon cancer resection specimensGarrett M Nash
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Ann Surg 253:318-22. 2011..To develop a predictive model of lymph node yield in a series of colon cancer resection specimens with detailed anatomic and surgical technique data...
Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 casesWilbur B Bowne
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 48:897-909. 2005..Complete resection is critical to long-term survival and is associated with a single site of recurrence, perianastomotic disease, low presalvage carcinembryonic antigen level, and absence of distant disease...
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatmentGeorge A Poultsides
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 27:3379-84. 2009....
Identification of patients with high-risk stage II colon cancer for adjuvant therapyHak Mien Quah
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 51:503-7. 2008..The purpose of this study was to assess the prognostic significance of commonly reported clinicopathologic features of Stage II colon cancer to identify high-risk patients...
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panelJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg Pathol 33:1639-45. 2009..Such a cost-effective approach carries significant implication, as immunohistochemistry is being widely used as first-line screening for HNPCC...
Surgical salvage of recurrent rectal cancer after transanal excisionMartin R Weiser
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 48:1169-75. 2005..This study examines surgical salvage of locally recurrent rectal cancer following transanal excision of early tumors...
Limitations of early rectal cancer nodal staging may explain failure after local excisionRon G Landmann
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 50:1520-5. 2007..The limitations of endorectal ultrasound in accurately staging nodal disease in early rectal lesions may, in part, explain the relatively high recurrence rates seen after local excision...
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissectionMartin R Weiser
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 249:236-42. 2009....
Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapyAnand Govindarajan
Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 29:4568-73. 2011..We sought to examine the feasibility and clinical significance of current guidelines on nodal assessment in patients with rectal cancer (RC) treated with neoadjuvant radiation...
Long-term survival after transanal excision of T1 rectal cancerGarrett M Nash
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Dis Colon Rectum 52:577-82. 2009..However, the impact of transanal excision on cancer mortality has not been adequately studied. The purpose of this study was to compare oncologic outcomes of transanal excision with those of radical resection...
Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical managementJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 245:560-5. 2007..This study summarizes our initial experience with prospective, single-amplicon (mutation-specific) A636P testing in Ashkenazi Jewish patients at risk for Hereditary Nonpolyposis Colorectal Cancer (HNPCC)...
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapyRobert P Akbari
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 47:1136-44. 2004..persistence) after chemoradiation (when salvage is potentially curative), absence of nodal disease at salvage, and negative margins. Salvage inguinal lymph node dissection after failed chemoradiation therapy also is potentially curative...
Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument?Heather B Neuman
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
Ann Surg Oncol 14:1727-34. 2007....
Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapyAnne Y Lin
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Colorectal Dis 23:243-9. 2008..The aim of this study was to identify pretreatment factors associated with poor tumor response to neoadjuvant chemoradiation...
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excisionAnand Govindarajan
Department of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 18:3666-72. 2011..Patients with pathologically node-negative tumors have an improved prognosis, but recurrence patterns and independent prognostic factors in these patients have been incompletely characterized...
A636P testing in Ashkenazi JewsJose G Guillem
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Fam Cancer 3:223-7. 2004..In addition, we summarize our initial experience with a prospective A636P testing protocol aimed at Ashkenazi Jewish patients at high or intermediate risk for harboring the A636P mutation...
Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancerJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10002, USA
Am J Surg Pathol 27:1407-17. 2003..Using a stepwise logistic regression model, a formula was generated that could be used to calculate the probability of a colorectal carcinoma being MSI-H based on morphologic features...
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapyJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg Pathol 35:127-34. 2011....
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resectionHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 47:279-86. 2004....
Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcomeJames J Mezhir
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 256:274-9. 2012..We set out to determine the long-term oncologic impact of resection margins in patients with locally advanced rectal cancer using a comprehensive pathologic whole-mount section analysis...
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 256:111-6. 2012..To characterize patterns of recurrence in locally advanced rectal cancer treated with combined modality therapy (CMT): neoadjuvant chemoradiation + total mesorectal excision + adjuvant chemotherapy...
Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysisHeather B Neuman
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Dis Colon Rectum 52:863-71. 2009..Therefore, the objective was to develop a decision-analytic model to evaluate the relative benefits of surgery vs. observation in rectal cancer patients who achieve clinical complete response after neoadjuvant chemoradiation...
Colorectal cancer pelvic recurrences: determinants of resectabilityHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 47:1599-606. 2004..Efforts to enhance preoperative identification and imaging of these patients are clearly justified...
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapyLeyo Ruo
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 236:75-81. 2002..The presence of poor histopathologic features and positive nodal status are the most important prognostic indicators after neoadjuvant therapy...
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiationCaio S R Nahas
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 15:704-11. 2008....
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warrantedJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Clin Oncol 26:368-73. 2008..We therefore determined the accuracy of pre-CMT ERUS or magnetic resonance imaging (MRI) staging, to explore the validity of a nonpreoperative CMT approach for cT3N0 disease...
Feasibility of ex vivo FDG PET of the colonMarc J Gollub
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10023, USA
Radiology 252:232-9. 2009....
T1 adenocarcinoma of the rectum: transanal excision or radical surgery?David J Bentrem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 242:472-7; discussion 477-9. 2005..We performed a retrospective evaluation of patients with T1 rectal cancers treated by either transanal excision or radical resection at our institution to assess patient selection, cancer recurrence, and survival...
The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancerDavid B Chessin
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 201:948-56. 2005
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resectionDeborah Schrag
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Surg Oncol 83:68-78; discussion 78-9. 2003..However, the importance of surgeon case volume as a determinant of outcome has been less well studied, and it is unclear whether hospital or surgeon volume is the more powerful predictor of outcomes...
Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesionsMarc J Gollub
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Rm C276F, New York, NY 10021, USA
AJR Am J Roentgenol 188:130-8. 2007..The purpose of this study was to determine the feasibility of imaging the colon with fused CT colonography (CTC) and 18F-FDG PET and to correlate the findings with the histologic features of polyps...
Individualized prediction of colon cancer recurrence using a nomogramMartin R Weiser
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 26:380-5. 2008..Although easy to implement, there remains significant heterogeneity within each stage grouping. In the era of multimodality treatment, a more refined tool is needed to predict recurrence...
Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resectionGarrett M Nash
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Dis Colon Rectum 53:1365-73. 2010..Negative surgical margins are important for local control of rectal cancer treated with sphincter-preserving surgery. However, the association of rectal cancer recurrence with close distal margin is not well established...
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapyAntonio I Picon
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10021, New York, USA
Int J Colorectal Dis 18:487-92. 2003..CONCLUSION. Our data suggest that the extent of gross, or microscopic perirectal fat invasion (defined as >3 or </=3 mm), determined in the resected specimen, does not predict outcome in select T3 N0 rectal cancers...
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?Francesco Stipa
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 11:187-91. 2004....
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapyHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 10:80-5. 2003..CONCLUSIONS: Our data suggest that for patients with locally advanced rectal cancer undergoing resection and preoperative CMT, distal margins < or = 1 cm do not seem to compromise oncological outcome...
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancerMatthew S Katz
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 62:1363-70. 2005....
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessmentBridget N Fahy
Department of Surgery, Division of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:396-404. 2007..Predicting rectal carcinoid behavior exclusively on the basis of tumor size is imprecise. We sought to identify factors associated with outcome and incorporate them into a preoperative risk stratification scheme...
Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resectionEmily Steinhagen
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Am Coll Surg 214:61-7. 2012..Our study describes the impact of routine immunohistochemistry (IHC) analysis of tumor tissue for loss of MMR protein expression in early age-of-onset CRC patients undergoing resection...
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV diseaseGarrett M Nash
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 9:954-60. 2002..The extent of metastatic disease and the response to chemotherapy are the major determinants of survival. Effective systemic chemotherapy should be given high priority in the treatment of stage IV rectal cancer...
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?Jinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 32:719-31. 2008..These tumors are clinically aggressive. Prospective studies using defined diagnostic criteria are needed to determine their biologic characteristics and optimal management...
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significanceAnne Lin
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 38:850-6. 2007..Further investigation on interaction between AMACR and other known colorectal cancer development pathways may provide new insights on colorectal carcinogenesis...
The role of abdominoperineal resection as surgical therapy for anorectal melanomaJen Jen Yeh
Memorial-Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 244:1012-7. 2006..Therefore, LE of the primary tumor is recommended when technically feasible. The presence of PNI is an important prognostic factor and should be considered in future clinical trials...
Primary adenocarcinoma of the anus treated with combined modality therapyKathryn P Beal
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 46:1320-4. 2003..CONCLUSION: Although the experience is limited, our data suggest that the combination of abdominoperineal resection and combined modality therapy is a reasonable approach for this rare tumor...
Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapyJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Am J Surg Pathol 26:863-72. 2002..The possible mechanism for the increased endocrine cells in treated rectal adenocarcinomas may be related to induction of endocrine differentiation in tumor cells by cytotoxic insult...
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancerLarissa K Temple
Department of Surgery, Division of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 48:1353-65. 2005..Therefore, the purpose of this study was to develop an instrument to evaluate bowel function after sphincter-preserving surgery...
Initial experience with transanal endoscopic microsurgery: the need for understanding the limitationsEmily Steinhagen
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, C 1077, New York, NY 10065, USA
J Gastrointest Surg 15:958-62. 2011..Compared to radical resection, patients experience lower rates of morbidity and mortality but may have higher rates of local recurrence...
A636P is associated with early-onset colon cancer in Ashkenazi JewsJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 196:222-5. 2003..This study seeks to characterize the proportion of individuals of Ashkenazi heritage with very early-onset colon cancer (diagnosed at age 40 or younger) that could be attributed to MSH2*1906C>G...
Multimodality management of locally advanced rectal cancerHarvey G Moore
Colorectal Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Am Surg 69:612-9. 2003..Efforts are currently directed at identifying the subset of locally advanced rectal cancer patients who may be adequately treated with a resection alone thereby avoiding the added morbidity of adjuvant radiation and chemotherapy...
MSH6 germline mutations are rare in colorectal cancer familiesPaolo Peterlongo
Cell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Cancer 107:571-9. 2003..Altogether, our results indicate that disease-causing germline mutations of MSH6 are rare in HNPCC and HNPCC-like families...
Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgeryLeyo Ruo
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Gastrointest Surg 6:671-5. 2002..Good long-term prognosis can be expected in completely resected patients although subsequent proliferative and/or neoplastic lesions may still be detected in the gastrointestinal tract with prolonged follow-up...
Contemporary applications of transanal endoscopic microsurgery: technical innovations and limitationsJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Rm C 1077, New York, NY 10021, USA
Clin Colorectal Cancer 5:268-73. 2005..This report summarizes the recent literature concerning TEM, comprehensively analyzes the authors' experience with TEM, and describes recent technical innovations and indications...
Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapyMargo Shoup
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 45:585-92. 2002..CONCLUSION: Resection with negative microscopic margins and absence of vascular invasion are independent predictors of local control and improved survival after resection and intraoperative radiotherapy for recurrent rectal cancer...
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room C 1077, New York, New York 10021, USA
Ann Surg Oncol 13:1296-321. 2006..Clinical interventions have been formulated for mutation carriers within affected families. The primary interventions for mutation carriers of highly penetrant syndromes are surgical...
Long-term results of local excision for rectal cancerPhilip B Paty
Department of Surgery, Pathology, and Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 236:522-29; discussion 529-30. 2002..To review the authors' experience with local excision of early rectal cancers to assess the effectiveness of initial treatment and of salvage surgery...
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastasesZhao Shi Zeng
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 8:144-8. 2002..The aim of this study is to examine the MMP-7 expression in the human colorectal cancer (CRC) liver metastases and normal liver tissue using multiple techniques and to determine its association with liver metastases formation...
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patientsHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 197:22-8. 2003..Its reliability appears to improve with time, perhaps because of resolution of early postradiation inflammation...
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resectionDeborah Schrag
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Department of Medicine, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 236:583-92. 2002..To compare surgeon and hospital procedure volume as predictors of outcomes for patients with rectal cancer...
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significanceJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 39:498-505. 2008..The significance of such an association as well as the prognostic value of FRalpha expression deserves further exploration...
Anal neoplasmsHarvey G Moore
Colorectal Surgery Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Surg Clin North Am 82:1233-51. 2002..The prognosis for anorectal melanoma, as well as for small cell and undifferentiated tumors, continues to be poor. Fortunately, these are relatively rare tumors...
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patientsSpiros P Hiotis
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA
J Am Coll Surg 194:131-5; discussion 135-6. 2002..Our data suggest that all acceptable-risk patients with a diagnosis of primary rectal cancer should undergo resection, regardless of their response to preoperative therapy...
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patientsLeyo Ruo
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 196:722-8. 2003..Limited metastatic tumor burden and less extensive liver involvement were associated with better survival and a higher likelihood of benefit from elective bowel resection in asymptomatic patients with incurable stage IV CRC...
Surgical treatment of rectal cancer: radical resectionSeung-Yong Jeong
Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, NY 10021, USA
Surg Oncol Clin N Am 15:95-107, vi-vii. 2006..This article reviews the surgical management of primary rectal cancer and discusses major surgical considerations in the treatment of this disease...
Surgical issues in rectal cancer: a 2004 updateDavid B Chessin
Colorectal Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Clin Colorectal Cancer 4:233-40. 2004..Our aim is to outline some of the important surgical issues surrounding the management of patients with early-stage (T1/T2 N0) or locally advanced (T3/T4 and/or N1) rectal cancer...
Symptom control in patients with locally recurrent rectal cancerThomas J Miner
Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 10:72-9. 2003..CONCLUSIONS: Although symptomatic relief is associated with repeat surgery, the recurrence or development of alternate symptoms makes a completely asymptomatic clinical course uncommon...
Long-term outcome of perianal Paget's diseaseMartin D McCarter
Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 46:612-6. 2003..Patients with invasive malignancies require more extensive surgery. The role of chemoradiotherapy remains undefined in this disease...
Abdominoperineal resection for rectal cancer: historic perspective and current issuesDavid B Chessin
Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1083, New York, NY 10021, USA
Surg Oncol Clin N Am 14:569-86, vii. 2005
Surgical management of isolated retroperitoneal recurrences of colorectal carcinomaDavid Shibata
Division of Surgical Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA
Dis Colon Rectum 45:795-801. 2002..However, a longer disease-free interval, complete negative-margin resection, and smaller tumor size are associated with long-term survival in selected patients...
Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition stagingSeung-Yong Jeong
J Natl Cancer Inst 97:1705-6; author reply 1706-7. 2005
Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancerJose G Guillem
Ann Surg Oncol 10:824. 2003
